These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18198348)

  • 1. Differential requirement for DOCK2 in migration of plasmacytoid dendritic cells versus myeloid dendritic cells.
    Gotoh K; Tanaka Y; Nishikimi A; Inayoshi A; Enjoji M; Takayanagi R; Sasazuki T; Fukui Y
    Blood; 2008 Mar; 111(6):2973-6. PubMed ID: 18198348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of Dock2 on macrophage migration and functions during Citrobacter rodentium infection.
    Ji L; Chen Y; Xie L; Liu Z
    Clin Exp Immunol; 2021 Jun; 204(3):361-372. PubMed ID: 33662140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective control of type I IFN induction by the Rac activator DOCK2 during TLR-mediated plasmacytoid dendritic cell activation.
    Gotoh K; Tanaka Y; Nishikimi A; Nakamura R; Yamada H; Maeda N; Ishikawa T; Hoshino K; Uruno T; Cao Q; Higashi S; Kawaguchi Y; Enjoji M; Takayanagi R; Kaisho T; Yoshikai Y; Fukui Y
    J Exp Med; 2010 Apr; 207(4):721-30. PubMed ID: 20231379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dimerization of DOCK2 is essential for DOCK2-mediated Rac activation and lymphocyte migration.
    Terasawa M; Uruno T; Mori S; Kukimoto-Niino M; Nishikimi A; Sanematsu F; Tanaka Y; Yokoyama S; Fukui Y
    PLoS One; 2012; 7(9):e46277. PubMed ID: 23050005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DOCK2 is a Rac activator that regulates motility and polarity during neutrophil chemotaxis.
    Kunisaki Y; Nishikimi A; Tanaka Y; Takii R; Noda M; Inayoshi A; Watanabe K; Sanematsu F; Sasazuki T; Sasaki T; Fukui Y
    J Cell Biol; 2006 Aug; 174(5):647-52. PubMed ID: 16943182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haematopoietic cell-specific CDM family protein DOCK2 is essential for lymphocyte migration.
    Fukui Y; Hashimoto O; Sanui T; Oono T; Koga H; Abe M; Inayoshi A; Noda M; Oike M; Shirai T; Sasazuki T
    Nature; 2001 Aug; 412(6849):826-31. PubMed ID: 11518968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential migration behavior and chemokine production by myeloid and plasmacytoid dendritic cells.
    Penna G; Vulcano M; Sozzani S; Adorini L
    Hum Immunol; 2002 Dec; 63(12):1164-71. PubMed ID: 12480260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DOCK2 and DOCK5 act additively in neutrophils to regulate chemotaxis, superoxide production, and extracellular trap formation.
    Watanabe M; Terasawa M; Miyano K; Yanagihara T; Uruno T; Sanematsu F; Nishikimi A; Côté JF; Sumimoto H; Fukui Y
    J Immunol; 2014 Dec; 193(11):5660-7. PubMed ID: 25339677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A central role for DOCK2 during interstitial lymphocyte motility and sphingosine-1-phosphate-mediated egress.
    Nombela-Arrieta C; Mempel TR; Soriano SF; Mazo I; Wymann MP; Hirsch E; Martínez-A C; Fukui Y; von Andrian UH; Stein JV
    J Exp Med; 2007 Mar; 204(3):497-510. PubMed ID: 17325199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DOCK2 regulates chemokine-triggered lateral lymphocyte motility but not transendothelial migration.
    Shulman Z; Pasvolsky R; Woolf E; Grabovsky V; Feigelson SW; Erez N; Fukui Y; Alon R
    Blood; 2006 Oct; 108(7):2150-8. PubMed ID: 16772603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Rac activator DOCK2 regulates natural killer cell-mediated cytotoxicity in mice through the lytic synapse formation.
    Sakai Y; Tanaka Y; Yanagihara T; Watanabe M; Duan X; Terasawa M; Nishikimi A; Sanematsu F; Fukui Y
    Blood; 2013 Jul; 122(3):386-93. PubMed ID: 23719299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inflammasome adaptor ASC regulates the function of adaptive immune cells by controlling Dock2-mediated Rac activation and actin polymerization.
    Ippagunta SK; Malireddi RK; Shaw PJ; Neale GA; Vande Walle L; Green DR; Fukui Y; Lamkanfi M; Kanneganti TD
    Nat Immunol; 2011 Sep; 12(10):1010-6. PubMed ID: 21892172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotype and function of B cells and dendritic cells from interferon regulatory factor 5-deficient mice with and without a mutation in DOCK2.
    Yasuda K; Nündel K; Watkins AA; Dhawan T; Bonegio RG; Ubellacker JM; Marshak-Rothstein A; Rifkin IR
    Int Immunol; 2013 May; 25(5):295-306. PubMed ID: 23291967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of DOCK2 and DOCK180 in fetal thymus colonization.
    Lei Y; Liu C; Saito F; Fukui Y; Takahama Y
    Eur J Immunol; 2009 Oct; 39(10):2695-702. PubMed ID: 19728314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dedicator of cytokinesis protein 2 couples with lymphoid enhancer-binding factor 1 to regulate expression of CD21 and B-cell differentiation.
    Jing Y; Kang D; Liu L; Huang H; Chen A; Yang L; Jiang P; Li N; Miller H; Liu Z; Zhu X; Yang J; Wang X; Sun J; Liu Z; Liu W; Zhou X; Liu C
    J Allergy Clin Immunol; 2019 Nov; 144(5):1377-1390.e4. PubMed ID: 31405607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-alpha differentially affects homeostasis of human plasmacytoid and myeloid dendritic cells.
    Cicinnati VR; Kang J; Hou J; Lindemann M; Koop K; Tüting T; Gerken G; Beckebaum S
    J Interferon Cytokine Res; 2009 Mar; 29(3):145-60. PubMed ID: 19196069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen Availability and DOCK2-Driven Motility Govern CD4
    Ackerknecht M; Gollmer K; Germann P; Ficht X; Abe J; Fukui Y; Swoger J; Ripoll J; Sharpe J; Stein JV
    J Immunol; 2017 Jul; 199(2):520-530. PubMed ID: 28607113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CDM protein DOCK2 in lymphocyte migration.
    Reif K; Cyster J
    Trends Cell Biol; 2002 Aug; 12(8):368-73. PubMed ID: 12191913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Rac Activator DOCK2 Mediates Plasma Cell Differentiation and IgG Antibody Production.
    Ushijima M; Uruno T; Nishikimi A; Sanematsu F; Kamikaseda Y; Kunimura K; Sakata D; Okada T; Fukui Y
    Front Immunol; 2018; 9():243. PubMed ID: 29503648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential role of Elmo1 in Dock2-dependent lymphocyte migration.
    Stevenson C; de la Rosa G; Anderson CS; Murphy PS; Capece T; Kim M; Elliott MR
    J Immunol; 2014 Jun; 192(12):6062-70. PubMed ID: 24821968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.